Ascentage Pharma Group International (AAPG) Total Non-Current Liabilities: 2023-2024
Historic Total Non-Current Liabilities for Ascentage Pharma Group International (AAPG) over the last 2 years, with Dec 2024 value amounting to $161.3 million.
- Ascentage Pharma Group International's Total Non-Current Liabilities fell 22.37% to $161.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $161.3 million, marking a year-over-year decrease of 22.37%. This contributed to the annual value of $161.3 million for FY2024, which is 23.80% down from last year.
- As of FY2024, Ascentage Pharma Group International's Total Non-Current Liabilities stood at $161.3 million, which was down 23.80% from $211.6 million recorded in FY2023.
- Over the past 5 years, Ascentage Pharma Group International's Total Non-Current Liabilities peaked at $211.6 million during FY2023, and registered a low of $161.3 million during FY2024.
- Moreover, its 2-year median value for Total Non-Current Liabilities was $186.4 million (2024), whereas its average is $186.4 million.
- Data for Ascentage Pharma Group International's Total Non-Current Liabilities shows a maximum YoY dropped of 23.80% (in 2024) over the last 5 years.
- Yearly analysis of 2 years shows Ascentage Pharma Group International's Total Non-Current Liabilities stood at $211.6 million in 2023, then decreased by 23.80% to $161.3 million in 2024.